AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NANOVIRICIDES, INC. Director's Dealing 2009

May 18, 2009

34915_dirs_2009-05-18_1690e001-7068-42e2-89bf-1093b2008c51.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NANOVIRICIDES, INC. (NNVC.OB)
CIK: 0001379006
Period of Report: 2009-05-11

Reporting Person: Theracour Pharma, Inc. (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2009-05-11	Common Stock	S	10000	$.66	Disposed	34791500	Direct
2009-05-14	Common Stock	S	10000	$.62	Disposed	34781500	Direct
2009-05-15	Common Stock	S	10000	$.62	Disposed	34771500	Direct

Footnotes

F1: Represents shares of common stock sold in accordance with TheraCour?s Rule 10b5-1 Trading Plan adopted with the Registrant as disclosed on Form 8-K on February 10, 2009.